David M Mott is of NOVAVAX INC. Currently has a direct ownership of 50,470 shares of NVAX, which is worth approximately $600,593. The most recent transaction as insider was on Jun 12, 2024, when has been sold 6,670 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.5K
15.23% 3M change
15.23% 12M change
Total Value Held $600,593

DAVID M MOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
6,670 Added 11.67%
50,470 Common Stock
Jun 10 2023
BUY
Exercise of conversion of derivative security
-
3,100 Added 6.61%
43,800 Common Stock
Jun 17 2022
BUY
Exercise of conversion of derivative security
-
700 Added 1.69%
40,700 Common Stock
Sep 23 2021
SELL
Open market or private sale
$6,326,116 $253.44 p/Share
24,961 Reduced 38.42%
40,000 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
MRSN
Mersana Therapeutics, Inc. Healthcare
ARDX
ARDELYX, INC. Healthcare
IMRA
IMARA Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
DMM

David M Mott

Big Sky, MT

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX